161 related articles for article (PubMed ID: 15894682)
1. CYP3A43 Pro(340)Ala polymorphism and prostate cancer risk in African Americans and Caucasians.
Stone A; Ratnasinghe LD; Emerson GL; Modali R; Lehman T; Runnells G; Carroll A; Carter W; Barnhart S; Rasheed AA; Greene G; Johnson DE; Ambrosone CB; Kadlubar FF; Lang NP
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1257-61. PubMed ID: 15894682
[TBL] [Abstract][Full Text] [Related]
2. Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African-Americans, Caucasians and Chinese; oestradiol hydroxylase activity; and distribution in prostate cancer cases and controls.
Tang YM; Green BL; Chen GF; Thompson PA; Lang NP; Shinde A; Lin DX; Tan W; Lyn-Cook BD; Hammons GJ; Kadlubar FF
Pharmacogenetics; 2000 Dec; 10(9):761-6. PubMed ID: 11221602
[TBL] [Abstract][Full Text] [Related]
3. Manganese superoxide dismutase Ala-9Val polymorphism and risk of breast cancer in a population-based case-control study of African Americans and whites.
Millikan RC; Player J; de Cotret AR; Moorman P; Pittman G; Vannappagari V; Tse CK; Keku T
Breast Cancer Res; 2004; 6(4):R264-74. PubMed ID: 15217492
[TBL] [Abstract][Full Text] [Related]
4. Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men.
Park J; Chen L; Ratnashinge L; Sellers TA; Tanner JP; Lee JH; Dossett N; Lang N; Kadlubar FF; Ambrosone CB; Zachariah B; Heysek RV; Patterson S; Pow-Sang J
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1473-8. PubMed ID: 16896035
[TBL] [Abstract][Full Text] [Related]
5. CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer.
Zeigler-Johnson C; Friebel T; Walker AH; Wang Y; Spangler E; Panossian S; Patacsil M; Aplenc R; Wein AJ; Malkowicz SB; Rebbeck TR
Cancer Res; 2004 Nov; 64(22):8461-7. PubMed ID: 15548719
[TBL] [Abstract][Full Text] [Related]
6. Association of SULT1A1 phenotype and genotype with prostate cancer risk in African-Americans and Caucasians.
Nowell S; Ratnasinghe DL; Ambrosone CB; Williams S; Teague-Ross T; Trimble L; Runnels G; Carrol A; Green B; Stone A; Johnson D; Greene G; Kadlubar FF; Lang NP
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):270-6. PubMed ID: 14973106
[TBL] [Abstract][Full Text] [Related]
7. Combinations of cytochrome P-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study.
Cote ML; Wenzlaff AS; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Lung Cancer; 2007 Mar; 55(3):255-62. PubMed ID: 17174438
[TBL] [Abstract][Full Text] [Related]
8. Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men.
Bangsi D; Zhou J; Sun Y; Patel NP; Darga LL; Heilbrun LK; Powell IJ; Severson RK; Everson RB
Urol Oncol; 2006; 24(1):21-7. PubMed ID: 16414488
[TBL] [Abstract][Full Text] [Related]
9. Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk and aggressiveness in a Korean study population.
Han JH; Lee YS; Kim HJ; Lee SY; Myung SC
Asian J Androl; 2015; 17(2):285-91. PubMed ID: 25337833
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer risk in relation to the CYP2C9*1/CYP2C9*2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California.
London SJ; Daly AK; Leathart JB; Navidi WC; Idle JR
Pharmacogenetics; 1996 Dec; 6(6):527-33. PubMed ID: 9014202
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma.
Katkoori VR; Jia X; Shanmugam C; Wan W; Meleth S; Bumpers H; Grizzle WE; Manne U
Clin Cancer Res; 2009 Apr; 15(7):2406-16. PubMed ID: 19339276
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California.
London SJ; Daly AK; Cooper J; Navidi WC; Carpenter CL; Idle JR
J Natl Cancer Inst; 1995 Aug; 87(16):1246-53. PubMed ID: 7563171
[TBL] [Abstract][Full Text] [Related]
13. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
[TBL] [Abstract][Full Text] [Related]
14. Warfarin response and vitamin K epoxide reductase complex 1 in African Americans and Caucasians.
Schelleman H; Chen Z; Kealey C; Whitehead AS; Christie J; Price M; Brensinger CM; Newcomb CW; Thorn CF; Samaha FF; Kimmel SE
Clin Pharmacol Ther; 2007 May; 81(5):742-7. PubMed ID: 17329985
[TBL] [Abstract][Full Text] [Related]
15. No influence of CYP3A43 rs472660G> A on steady-state serum olanzapine concentrations in white psychiatric patients.
Söderberg MM; Molden E; Dahl ML
Pharmacogenet Genomics; 2014 May; 24(5):272-5. PubMed ID: 24595013
[TBL] [Abstract][Full Text] [Related]
16. Decision tree-based modeling of androgen pathway genes and prostate cancer risk.
Barnholtz-Sloan JS; Guan X; Zeigler-Johnson C; Meropol NJ; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1146-55. PubMed ID: 21493872
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County.
London SJ; Daly AK; Leathart JB; Navidi WC; Carpenter CC; Idle JR
Carcinogenesis; 1997 Jun; 18(6):1203-14. PubMed ID: 9214604
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of low calcium intake and low calcium absorption vitamin D receptor genotype in the California Collaborative Prostate Cancer Study.
Rowland GW; Schwartz GG; John EM; Ingles SA
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):16-24. PubMed ID: 23129590
[TBL] [Abstract][Full Text] [Related]
19. GSTM1 Gene Polymorphism is Implicated in Increased Susceptibility to Prostate Cancer in Caucasians and Asians.
Wang ZY; Li HY; Jiang Z; Zhou TB; Drummen GP
Technol Cancer Res Treat; 2016 Dec; 15(6):NP69-NP78. PubMed ID: 26614779
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in CYP3A43 explains racial difference in olanzapine clearance.
Bigos KL; Bies RR; Pollock BG; Lowy JJ; Zhang F; Weinberger DR
Mol Psychiatry; 2011 Jun; 16(6):620-5. PubMed ID: 21519338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
